Survey and trial data

What Is a Bad Trip, and What Helps?

Nobody plans a bad trip. They happen anyway, and they're the main reason clinical trials never leave people alone. Here's what the research says about why they happen and how to get through one.

Short answer

A bad trip is a psychedelic experience dominated by fear, anxiety, paranoia, confusion, or overwhelming emotion. It usually passes as the drug wears off, within hours. Higher doses, a stressful setting, mixing substances, and certain mental health conditions raise the risk. In clinical settings, trained staff help people through these moments with reassurance and a calm environment, and many people later describe the hard part as worthwhile.

Key takeaways

  • Difficult experiences are common. Serious harm is not.
  • Mindset and environment, known as set and setting, were cited in nearly half of emergency visits in one large survey.
  • In a survey of almost 2,000 people, most said their worst mushroom trip was ultimately worth it, but 11% said they had put themselves or others at risk during it.
  • If someone has chest pain, a seizure, trouble breathing, or might hurt themselves or others, that's an emergency. Call 911.

What a bad trip actually is

"Bad trip" is a catch-all for a psychedelic experience that turns frightening or overwhelming. Researchers prefer the term challenging experience, partly because it's more precise and partly because, as you'll see, a lot of people end up glad they had one.

It can look like:

  • Intense fear or panic, sometimes about dying or going crazy
  • Paranoia, or feeling trapped
  • Confusion about where you are or what's real
  • Painful memories or emotions surfacing all at once
  • A feeling that the experience will never end

That last one is worth naming, because it's always false. Psilocybin wears off in four to six hours, every time. See how long shrooms last.

How common are bad trips?

The best data comes from a Johns Hopkins survey of 1,993 people who described their single most difficult experience on psilocybin mushrooms. Even among those worst-case trips, 84% said they benefited from the experience, and many ranked it among the most meaningful of their lives. The flip side: 11% said they put themselves or others at risk of physical harm during it, and 7.6% sought treatment afterward for lasting psychological symptoms.1

Emergencies are rare. In a survey of more than 9,000 people who used magic mushrooms, 0.2% had ever sought emergency medical treatment, and nearly all of them recovered within 24 hours.2

What raises the risk

When researchers asked those emergency patients what went wrong, the top answers weren't about the mushrooms at all. Nearly half blamed their mindset going in, 37% blamed an unsuitable environment, and about a third had mixed mushrooms with cannabis or alcohol.2 Other well-known risk factors include:

  • A higher dose than you expected. Mushroom potency varies a lot, so the same amount can hit very differently.
  • Redosing because the first dose seemed slow.
  • Being alone, or with people you don't trust.
  • Stress, grief, or conflict going on in your life right then.
  • A personal or family history of psychosis or bipolar disorder, which is a reason to avoid psilocybin entirely outside a medical setting.3

Set and setting, explained

"Set" is your mindset: your mood, expectations, intentions, and what's going on in your life. "Setting" is your surroundings: the physical space, the people, the sounds. The phrase dates to the 1960s, and decades of research since have shown these factors can shape a psychedelic experience nearly as much as the drug itself.4

Clinical trials engineer both. Participants meet their care team ahead of time, talk through what might come up, and take psilocybin in a quiet, comfortable room with eyeshades, curated music, and two trained monitors present for the whole session.3 In one Compass Pathways analysis, almost 80% of session time was spent in silence, with staff there for support, not direction.5

How clinicians handle a difficult moment

The Johns Hopkins safety guidelines describe a simple approach: keep the person safe, stay calm and present, and reassure them that what they're feeling is the drug and it will pass.3 Guides often encourage people to move toward a difficult feeling instead of fighting it, since resistance tends to make it worse. Practical steps include:

  • Moving to a quieter, familiar, or more comfortable space
  • Changing the music or turning it off
  • Slow breathing, and a trusted person sitting nearby
  • Reminding yourself, out loud if it helps, that it's temporary

Fireside Project offers free peer support by phone or text for people during or after a psychedelic experience.

When it's an emergency

Call 911 if someone has chest pain, a seizure, trouble breathing, loses consciousness, has a dangerously high temperature, or might hurt themselves or someone else. Tell responders what was taken. In the U.S., you can also call or text 988 for a mental health crisis. Being honest with medical staff about what was taken helps them give the right care.

Common questions

How long does a bad trip last?

As long as the drug does, usually a few hours. The most intense part tends to come around the peak, one to two hours in, and eases as the effects fade.

Can a bad trip cause lasting damage?

For most people, no. A small minority report anxiety or other psychological symptoms that last after the experience, and people with a personal or family history of psychosis or bipolar disorder face a higher risk of a serious episode. If symptoms persist, talk to a clinician.

Is there a hotline for bad trips?

Fireside Project runs a free psychedelic peer support line by phone and text. For anything that looks like a medical or psychiatric emergency, call 911 or the 988 Suicide and Crisis Lifeline.

Sources

  1. Carbonaro TM, et al. Survey study of challenging experiences after ingesting psilocybin mushrooms: acute and enduring positive and negative consequences. Journal of Psychopharmacology. 2016. doi.org/10.1177/0269881116662634
  2. Kopra EI, et al. Adverse experiences resulting in emergency medical treatment seeking following the use of magic mushrooms. Journal of Psychopharmacology. 2022. PMC9353971
  3. Johnson MW, Richards WA, Griffiths RR. Human hallucinogen research: guidelines for safety. Journal of Psychopharmacology. 2008. doi.org/10.1177/0269881108093587
  4. Hartogsohn I. Set and setting, psychedelics and the placebo response: an extra-pharmacological perspective on psychopharmacology. Journal of Psychopharmacology. 2016. doi.org/10.1177/0269881116677852
  5. Compass Pathways. Second quarter and first half 2026 financial results and business highlights. August 5, 2026. seekingalpha.com

This article is for education only and is not medical or legal advice. Psilocybin is a Schedule I substance under U.S. federal law. Talk with a licensed clinician before making decisions about your health. In a crisis, call or text 988.